BLUE SKY INVESTS IN PHARMACEUTICAL MARKET

Written on the 13 July 2015

BLUE SKY INVESTS IN PHARMACEUTICAL MARKET

BLUE Sky Private Equity is set to enter the $2.3 billion hospital pharmacy market, after purchasing a major stake in HPS.

The investment arm of Blue Sky Alternative Investments (ASX:BLA) teamed up with Partners Group to acquire the pharmacy services provider for an undisclosed amount.

HPS has an annual turnover of more than $130 million, backed by long-term contracts with Healthscope, Calvary and St John of God.

Blue Sky Private Equity investment director Nick Dignam says HPS' strong market share makes it a perfect fit in the company's portfolio.

"Expenditure on healthcare per capita is increasing, which is providing growth for hospital pharmacies' key customers, hospitals and oncology facilities," Dignam says.

"While we are sector agnostic, our investments tend to focus around the essentials, the things that people need, rather than want.

"HPS' management team also has a deep industry experience. They have built an excellent business relying on long-term contracts and a high rate of customer retention."

Blue Sky Private Equity and Partners Group plan to increase the network of pharmacies within hospitals, and expand into adjacent markets.

As the leading provider of outsourced hospital and oncology pharmacy services in Australia, HPS is running trials for the production of compounded chemotherapy drugs.

The trials at two separate facilities are awaiting Therapeutic Goods Administration (TGA) approval.

HPS CEO Tony Wyatt says the hospital pharmacy market alone is growing rapidly.

"The growth in hospital pharmacy services is driven by an ageing and growing population, higher incidence rates of chronic diseases including cancer and the increasing ability to medically treat patients," Wyatt says.

"The current trend towards state governments partnering with the private sector to operate and service public hospitals is also leading to an increased trend towards outsourcing hospital pharmacy services.

"We provide a high level of support to the pharmacy network, enabling them to provide a better service, which ultimately means better care to clients, patients and the wider community."

The $15.3 billion pharmacy market is split between retail and hospital pharmacies in Australia.

 

Have you ever thought of taking a chance at alternative investments? That's what Mark Sowerby, founder of Blue Sky Alternative Investments (ASX:BLA), does every day.

As founder and managing director of Australia's first diversified alternatives asset manager, Sowerby is well versed in investment opportunities beyond traditional markets.

Sowerby, who has grown Blue Sky's assets under management to $1.35 billion in the past nine years, knows what it takes to test his comfort zone. He has just returned from a personal journey to the UK where he swam the English Channel.

Don't miss the opportunity to hear from one of Brisbane's most inspiring entrepreneurs at this special Brisbane Business News event.


Latest News

SUPREME COURT ORDERS OCTAVIAR GROUP TO WIND UP

THE Queensland Supreme Court has ordered the Octaviar Group of companies (formerly known as MFS Group) to be wound...

CEOS BRAVE THE COLD TO RAISE $1.4 MILLION FOR THE HOMELESS

MORE than 400 executives confronted the cold last night in the annual Vinnies CEO sleepout, which took place benea...

JENNIFER WESTACOTT ON BANK TAX: IT EXPOSES GOVERNMENT "DESPERATION"

South Australia's new bank levy exposes the desperation of a government that is unable to get its own budget and ...

BASKETBALL'S COMEBACK CONTINUES WITH NBL CLUBS TO FACE OFF AGAINST CHINA'S NATIONAL TEAM

THE RESURGENCE of Australia's National Basketball League (NBL) continues with China's national team to play t...

Related News

BASKETBALL'S COMEBACK CONTINUES WITH NBL CLUBS TO FACE OFF AGAINST CHINA'S NATIONAL TEAM

THE RESURGENCE of Australia's National Basketball League (NBL) continues with China's national team to play t...

DOMESTIC TOURISM IN AUSTRALIA BREAKS RECORDS, INJECTS $61.7 BILLION INTO NATIONAL ECONOMY

DOMESTIC Australian tourists have spent a record breaking $61.7 billion on intra and interstate travel this year, acc...

THE DOCTORS WHO PLUNGED INTO THE SHARK TANK AND SURVIVED WITH A $500,000 INVESTMENT

THEIR mission is to change the face of cancer care with an app that empowers and connects patients and care givers...

IMF BRACES FOR BIG LOSS FOLLOWING WITHDRAWAL FROM SPOTLESS CLASS ACTION

LITIGATION fund IMF Bentham (ASX: IMF) is set to lose as much as half a million dollars after it ceases funding one o...

BOOK YOUR FUNCTION SPACE HERE

 

 

 

Contact us

Email News Update Sign Up Contact Details
Subscriptions

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter